Cetera Investment Advisers

Position in NBIX — Neurocrine Biosciences Inc

CIK 1666741 SCHAUMBURG, IL

Position in NBIX

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$2,667,076

+$753,932 QoQ

Shares Held

20,245

+50.1% QoQ

Ownership

0.020%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

11 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Cetera Investment Advisers holds $48,125,230 across 32 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (5.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	80,566	$9,523,706
2	VTRS	Viatris Inc	385,999	$5,214,846
3	UTHR	UNITED THERAPEUTICS Corp	8,648	$5,128,091
4	TAK	Takeda Pharmaceutical Co Ltd	224,015	$4,148,757
5	ELAN	Elanco Animal Health Inc	121,502	$2,907,542
6	NBIX	Neurocrine Biosciences Inc This page	20,245	$2,667,076
7	TEVA	Teva Pharmaceutical Industries Ltd	87,216	$2,626,945
8	HLN	Haleon plc	247,741	$2,479,887

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,667,076	20,245	+50.1%	Shares	Sole	2026-05-13
2025-12-31	$1,913,144	13,489	+2.8%	Shares	Sole	2026-02-17
2025-09-30	$1,841,925	13,121	+44.8%	Shares	Sole	2025-11-14
2025-06-30	$1,138,751	9,060	-23.6%	Shares	Sole	2025-08-08
2025-03-31	$1,311,384	11,857	+45.1%	Shares	Sole	2025-05-06
2024-12-31	$1,115,068	8,169	+46.5%	Shares	Sole	2025-02-14
2024-09-30	$642,466	5,576	-21.6%	Shares	Sole	2024-11-13
2024-06-30	$979,109	7,112	+7.9%	Shares	Sole	2024-08-22
2024-03-31	$909,306	6,593	+154.4%	Shares	Sole	2024-05-24
2023-03-31	$262,362	2,592	+30.8%	Shares	Sole	2023-05-15
2022-12-31	$236,730	1,982	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.